Skip to content
Back to ALMR

Alamar Biosciences, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
130
Purchases
2
Sales
128
Purchase value
$4.00M
Sale value
$47.50M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Qiming Corporate GP VI, Ltd.10% owner
Qiming GP VIII-HC, LLC10% owner
Qiming GP VIII, LLC10% owner
Qiming Managing Directors Fund VI, L.P.10% owner
Qiming Venture Partners VIII-HC, L.P.10% owner
Qiming Venture Partners VIII Investments, LLC10% owner
Qiming Venture Partners VI, L.P.10% owner
4
Filed Nov 13, 2026Period of report Nov 11, 20260001231919-26-001575
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 11, 2026
Common StockF1F21,694$29.34$49.70K157,273IndirectSee footnote
SaleNov 11, 2026
Common StockF3F256$30.63$1.72K157,217IndirectSee footnote
SaleNov 11, 2026
Common StockF1F462,944$29.34$1.85M5,844,859IndirectSee footnote
SaleNov 11, 2026
Common StockF3F42,084$30.63$63.83K5,842,775IndirectSee footnote
SaleNov 11, 2026
Common StockF1F514,687$29.34$430.92K1,363,787IndirectSee footnote
SaleNov 11, 2026
Common StockF3F5486$30.63$14.89K1,363,301IndirectSee footnote
SaleNov 11, 2026
Common StockF1F617,584$29.34$515.91K1,632,770IndirectSee footnote
SaleNov 11, 2026
Common StockF3F6582$30.63$17.83K1,632,188IndirectSee footnote
Filing footnotes · 6
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.40 to $30.22, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1) and (3) to this Form 4.
  2. F2These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.38 to $30.94, inclusive.
  4. F4These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  5. F5These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  6. F6These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
Open on SEC EDGAR
Qiming Corporate GP VI, Ltd.10% owner
Qiming GP VIII-HC, LLC10% owner
Qiming GP VIII, LLC10% owner
Qiming Managing Directors Fund VI, L.P.10% owner
Qiming Venture Partners VIII-HC, L.P.10% owner
Qiming Venture Partners VIII Investments, LLC10% owner
Qiming Venture Partners VI, L.P.10% owner
4
Filed Nov 5, 2026Period of report Nov 3, 20260001231919-26-001540
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 3, 2026
Common StockF1F21,946$29.89$58.17K158,967IndirectSee footnote
SaleNov 3, 2026
Common StockF1F372,301$29.89$2.16M5,907,803IndirectSee footnote
SaleNov 3, 2026
Common StockF1F416,870$29.89$504.24K1,378,474IndirectSee footnote
SaleNov 3, 2026
Common StockF1F520,196$29.89$603.66K1,650,354IndirectSee footnote
Filing footnotes · 5
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.40 to $30.22, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote
  2. F2These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  3. F3These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  4. F4These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  5. F5These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
Open on SEC EDGAR
Qiming Corporate GP VI, Ltd.10% owner
Qiming GP VIII-HC, LLC10% owner
Qiming GP VIII, LLC10% owner
Qiming Managing Directors Fund VI, L.P.10% owner
Qiming Venture Partners VIII-HC, L.P.10% owner
Qiming Venture Partners VIII Investments, LLC10% owner
Qiming Venture Partners VI, L.P.10% owner
4
Filed Nov 3, 2026Period of report Oct 30, 20260001231919-26-001531
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 2, 2026
Common StockF9F2763$29.84$22.77K160,916IndirectSee footnote
SaleNov 2, 2026
Common StockF23$30.63$91.89160,913IndirectSee footnote
SaleNov 2, 2026
Common StockF9F628,404$29.84$847.58K5,980,235IndirectSee footnote
SaleNov 2, 2026
Common StockF6131$30.63$4.01K5,980,104IndirectSee footnote
SaleNov 2, 2026
Common StockF9F76,628$29.84$197.78K1,395,374IndirectSee footnote
SaleNov 2, 2026
Common StockF730$30.63$918.901,395,344IndirectSee footnote
SaleNov 2, 2026
Common StockF9F87,935$29.84$236.78K1,670,586IndirectSee footnote
SaleNov 2, 2026
Common StockF836$30.63$1.10K1,670,550IndirectSee footnote
SaleOct 30, 2026
Common StockF1F21,309$29.93$39.18K162,882IndirectSee footnote
SaleOct 30, 2026
Common StockF3F21,080$30.70$33.16K161,802IndirectSee footnote
SaleOct 30, 2026
Common StockF4F292$31.96$2.94K161,710IndirectSee footnote
SaleOct 30, 2026
Common StockF5F231$33.31$1.03K161,679IndirectSee footnote
SaleOct 30, 2026
Common StockF1F648,659$29.93$1.46M6,053,320IndirectSee footnote
SaleOct 30, 2026
Common StockF3F640,112$30.70$1.23M6,013,208IndirectSee footnote
SaleOct 30, 2026
Common StockF4F63,400$31.96$108.66K6,009,808IndirectSee footnote
SaleOct 30, 2026
Common StockF5F61,169$33.31$38.94K6,008,639IndirectSee footnote
SaleOct 30, 2026
Common StockF1F711,354$29.93$339.83K1,412,427IndirectSee footnote
SaleOct 30, 2026
Common StockF3F79,359$30.70$287.32K1,403,068IndirectSee footnote
SaleOct 30, 2026
Common StockF4F7793$31.96$25.34K1,402,275IndirectSee footnote
SaleOct 30, 2026
Common StockF5F7273$33.31$9.09K1,402,002IndirectSee footnote
SaleOct 30, 2026
Common StockF1F813,593$29.93$406.84K1,691,003IndirectSee footnote
SaleOct 30, 2026
Common StockF3F811,205$30.70$343.99K1,679,798IndirectSee footnote
SaleOct 30, 2026
Common StockF4F8950$31.96$30.36K1,678,848IndirectSee footnote
SaleOct 30, 2026
Common StockF5F8327$33.31$10.89K1,678,521IndirectSee footnote
Filing footnotes · 9
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.49, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1), (3), (4), (5) and (9) to this Form 4.
  2. F2These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.50 to $31.46, inclusive.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.52 to $32.465, inclusive.
  5. F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.68 to $33.59, inclusive.
  6. F6These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  7. F7These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  8. F8These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  9. F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.44, inclusive.
Open on SEC EDGAR
Qiming Corporate GP VI, Ltd.10% owner
Qiming GP VIII-HC, LLC10% owner
Qiming GP VIII, LLC10% owner
Qiming Managing Directors Fund VI, L.P.10% owner
Qiming Venture Partners VIII-HC, L.P.10% owner
Qiming Venture Partners VIII Investments, LLC10% owner
Qiming Venture Partners VI, L.P.10% owner
4
Filed Oct 29, 2026Period of report Oct 27, 20260001231919-26-001508
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 28, 2026
Common StockF8F2948$32.47$30.78K165,005IndirectSee footnote
SaleOct 28, 2026
Common StockF9F2814$33.11$26.95K164,191IndirectSee footnote
SaleOct 28, 2026
Common StockF8F535,248$32.47$1.14M6,132,228IndirectSee footnote
SaleOct 28, 2026
Common StockF9F530,249$33.11$1.00M6,101,979IndirectSee footnote
SaleOct 28, 2026
Common StockF8F68,224$32.47$267.03K1,430,839IndirectSee footnote
SaleOct 28, 2026
Common StockF9F67,058$33.11$233.69K1,423,781IndirectSee footnote
SaleOct 28, 2026
Common StockF8F79,846$32.47$319.70K1,713,046IndirectSee footnote
SaleOct 28, 2026
Common StockF9F78,450$33.11$279.78K1,704,596IndirectSee footnote
SaleOct 27, 2026
Common StockF1F2134$30.33$4.06K167,304IndirectSee footnote
SaleOct 27, 2026
Common StockF3F2943$31.33$29.54K166,361IndirectSee footnote
SaleOct 27, 2026
Common StockF4F2408$31.88$13.01K165,953IndirectSee footnote
SaleOct 27, 2026
Common StockF1F54,960$30.33$150.44K6,217,656IndirectSee footnote
SaleOct 27, 2026
Common StockF3F535,049$31.33$1.10M6,182,607IndirectSee footnote
SaleOct 27, 2026
Common StockF4F515,131$31.88$482.38K6,167,476IndirectSee footnote
SaleOct 27, 2026
Common StockF1F61,157$30.33$35.09K1,450,772IndirectSee footnote
SaleOct 27, 2026
Common StockF3F68,178$31.33$256.22K1,442,594IndirectSee footnote
SaleOct 27, 2026
Common StockF4F63,531$31.88$112.57K1,439,063IndirectSee footnote
SaleOct 27, 2026
Common StockF1F71,386$30.33$42.04K1,736,909IndirectSee footnote
SaleOct 27, 2026
Common StockF3F79,791$31.33$306.75K1,727,118IndirectSee footnote
SaleOct 27, 2026
Common StockF4F74,226$31.88$134.72K1,722,892IndirectSee footnote
Filing footnotes · 9
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.76 to $30.67, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1), (3), (4), (8) and (9) to this Form 4.
  2. F2These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.765 to $31.75, inclusive.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.76 to $31.955, inclusive.
  5. F5These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  6. F6These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  7. F7These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  8. F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.87 to $32.865, inclusive.
  9. F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.87 to $33.745, inclusive.
Open on SEC EDGAR
Qiming Corporate GP VI, Ltd.10% owner
Qiming GP VIII-HC, LLC10% owner
Qiming GP VIII, LLC10% owner
Qiming Managing Directors Fund VI, L.P.10% owner
Qiming Venture Partners VIII-HC, L.P.10% owner
Qiming Venture Partners VIII Investments, LLC10% owner
Qiming Venture Partners VI, L.P.10% owner
4
Filed Oct 27, 2026Period of report Oct 23, 20260001231919-26-001501
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 26, 2026
Common StockF8F22,313$30.52$70.59K167,440IndirectSee footnote
SaleOct 26, 2026
Common StockF9F22$31.07$62.14167,438IndirectSee footnote
SaleOct 26, 2026
Common StockF8F586,008$30.52$2.62M6,222,686IndirectSee footnote
SaleOct 26, 2026
Common StockF9F570$31.07$2.17K6,222,616IndirectSee footnote
SaleOct 26, 2026
Common StockF8F620,069$30.52$612.51K1,451,945IndirectSee footnote
SaleOct 26, 2026
Common StockF9F616$31.07$497.121,451,929IndirectSee footnote
SaleOct 26, 2026
Common StockF8F724,027$30.52$733.30K1,738,314IndirectSee footnote
SaleOct 26, 2026
Common StockF9F719$31.07$590.331,738,295IndirectSee footnote
SaleOct 23, 2026
Common StockF1F2107$29.35$3.14K172,231IndirectSee footnote
SaleOct 23, 2026
Common StockF3F2832$30.23$25.15K171,399IndirectSee footnote
SaleOct 23, 2026
Common StockF4F21,646$30.85$50.78K169,753IndirectSee footnote
SaleOct 23, 2026
Common StockF1F53,975$29.35$116.67K6,400,806IndirectSee footnote
SaleOct 23, 2026
Common StockF3F530,921$30.23$934.74K6,369,885IndirectSee footnote
SaleOct 23, 2026
Common StockF4F561,191$30.85$1.89M6,308,694IndirectSee footnote
SaleOct 23, 2026
Common StockF1F6928$29.35$27.24K1,493,506IndirectSee footnote
SaleOct 23, 2026
Common StockF3F67,215$30.23$218.11K1,486,291IndirectSee footnote
SaleOct 23, 2026
Common StockF4F614,277$30.85$440.45K1,472,014IndirectSee footnote
SaleOct 23, 2026
Common StockF1F71,110$29.35$32.58K1,788,073IndirectSee footnote
SaleOct 23, 2026
Common StockF3F78,638$30.23$261.13K1,779,435IndirectSee footnote
SaleOct 23, 2026
Common StockF4F717,094$30.85$527.35K1,762,341IndirectSee footnote
Filing footnotes · 9
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.605 to $29.56, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1), (3), (4), (8) and (9) to this Form 4
  2. F2These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.62 to $30.61, inclusive.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.62 to $31.335, inclusive.
  5. F5These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  6. F6These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  7. F7These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  8. F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.07 to $31.065, inclusive.
  9. F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.07 to $31.115, inclusive.
Open on SEC EDGAR
Qiming Corporate GP VI, Ltd.10% owner
Qiming GP VIII-HC, LLC10% owner
Qiming GP VIII, LLC10% owner
Qiming Managing Directors Fund VI, L.P.10% owner
Qiming Venture Partners VIII-HC, L.P.10% owner
Qiming Venture Partners VIII Investments, LLC10% owner
Qiming Venture Partners VI, L.P.10% owner
4
Filed Oct 23, 2026Period of report Oct 21, 20260001231919-26-001497
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 22, 2026
Common StockF8F21,246$29.00$36.13K173,431IndirectSee footnote
SaleOct 22, 2026
Common StockF9F2994$29.59$29.41K172,437IndirectSee footnote
SaleOct 22, 2026
Common StockF10F299$30.81$3.05K172,338IndirectSee footnote
SaleOct 22, 2026
Common StockF8F546,290$29.00$1.34M6,445,405IndirectSee footnote
SaleOct 22, 2026
Common StockF9F536,941$29.59$1.09M6,408,464IndirectSee footnote
SaleOct 22, 2026
Common StockF10F53,683$30.81$113.47K6,404,781IndirectSee footnote
SaleOct 22, 2026
Common StockF8F610,800$29.00$313.20K1,503,913IndirectSee footnote
SaleOct 22, 2026
Common StockF9F68,620$29.59$255.07K1,495,293IndirectSee footnote
SaleOct 22, 2026
Common StockF10F6859$30.81$26.47K1,494,434IndirectSee footnote
SaleOct 22, 2026
Common StockF8F712,931$29.00$375.00K1,800,531IndirectSee footnote
SaleOct 22, 2026
Common StockF9F710,319$29.59$305.34K1,790,212IndirectSee footnote
SaleOct 22, 2026
Common StockF10F71,029$30.81$31.70K1,789,183IndirectSee footnote
SaleOct 21, 2026
Common StockF1F2592$29.01$17.17K177,734IndirectSee footnote
SaleOct 21, 2026
Common StockF3F2677$29.75$20.14K177,057IndirectSee footnote
SaleOct 21, 2026
Common StockF4F22,380$30.79$73.28K174,677IndirectSee footnote
SaleOct 21, 2026
Common StockF1F522,020$29.01$638.80K6,605,306IndirectSee footnote
SaleOct 21, 2026
Common StockF3F525,177$29.75$749.02K6,580,129IndirectSee footnote
SaleOct 21, 2026
Common StockF4F588,434$30.79$2.72M6,491,695IndirectSee footnote
SaleOct 21, 2026
Common StockF1F65,138$29.01$149.05K1,541,222IndirectSee footnote
SaleOct 21, 2026
Common StockF3F65,875$29.75$174.78K1,535,347IndirectSee footnote
SaleOct 21, 2026
Common StockF4F620,634$30.79$635.32K1,514,713IndirectSee footnote
SaleOct 21, 2026
Common StockF1F76,151$29.01$178.44K1,845,199IndirectSee footnote
SaleOct 21, 2026
Common StockF3F77,033$29.75$209.23K1,838,166IndirectSee footnote
SaleOct 21, 2026
Common StockF4F724,704$30.79$760.64K1,813,462IndirectSee footnote
Filing footnotes · 10
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.33 to $29.32, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1), (3), (4), (8), (9) and (10) to this Form 4
  2. F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.41 to $31.23, inclusive.
  3. F2These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  4. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.33 to $30.17, inclusive
  5. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.39 to $31.11, inclusive.
  6. F5These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  7. F6These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  8. F7These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  9. F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.36 to $29.355, inclusive.
  10. F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.36 to $30.33, inclusive.
Open on SEC EDGAR
Qiming Corporate GP VI, Ltd.10% owner
Qiming GP VIII-HC, LLC10% owner
Qiming GP VIII, LLC10% owner
Qiming Managing Directors Fund VI, L.P.10% owner
Qiming Venture Partners VIII-HC, L.P.10% owner
Qiming Venture Partners VIII Investments, LLC10% owner
Qiming Venture Partners VI, L.P.10% owner
4
Filed Oct 21, 2026Period of report Oct 19, 20260001231919-26-001485
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 20, 2026
Common StockF6F2200$26.63$5.33K180,608IndirectSee footnote
SaleOct 20, 2026
Common StockF7F21,947$27.93$54.38K178,661IndirectSee footnote
SaleOct 20, 2026
Common StockF8F2335$28.44$9.53K178,326IndirectSee footnote
SaleOct 20, 2026
Common StockF6F37,415$26.63$197.46K6,712,146IndirectSee footnote
SaleOct 20, 2026
Common StockF7F372,373$27.93$2.02M6,639,773IndirectSee footnote
SaleOct 20, 2026
Common StockF8F312,447$28.44$353.99K6,627,326IndirectSee footnote
SaleOct 20, 2026
Common StockF6F41,730$26.63$46.07K1,566,151IndirectSee footnote
SaleOct 20, 2026
Common StockF7F416,887$27.93$471.65K1,549,264IndirectSee footnote
SaleOct 20, 2026
Common StockF8F42,904$28.44$82.59K1,546,360IndirectSee footnote
SaleOct 20, 2026
Common StockF6F52,072$26.63$55.18K1,875,044IndirectSee footnote
SaleOct 20, 2026
Common StockF7F520,217$27.93$564.66K1,854,827IndirectSee footnote
SaleOct 20, 2026
Common StockF8F53,477$28.44$98.89K1,851,350IndirectSee footnote
SaleOct 19, 2026
Common StockF1F21,320$26.34$34.77K180,808IndirectSee footnote
SaleOct 19, 2026
Common StockF1F349,044$26.34$1.29M6,719,561IndirectSee footnote
SaleOct 19, 2026
Common StockF1F411,443$26.34$301.41K1,567,881IndirectSee footnote
SaleOct 19, 2026
Common StockF1F513,701$26.34$360.88K1,877,116IndirectSee footnote
Filing footnotes · 8
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2 to $26.52, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1) through (4) to this Form 4.
  2. F2These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  3. F3These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  4. F4These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  5. F5These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  6. F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.96, inclusive.
  7. F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.28 to $28.27, inclusive.
  8. F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.28 to $28.73, inclusive.
Open on SEC EDGAR
Qiming Corporate GP VI, Ltd.10% owner
Qiming GP VIII-HC, LLC10% owner
Qiming GP VIII, LLC10% owner
Qiming Managing Directors Fund VI, L.P.10% owner
Qiming Venture Partners VIII-HC, L.P.10% owner
Qiming Venture Partners VIII Investments, LLC10% owner
Qiming Venture Partners VI, L.P.10% owner
4
Filed Oct 19, 2026Period of report Oct 15, 20260001231919-26-001469
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 16, 2026
Common StockF22$27.02$54.04182,128IndirectSee footnote
SaleOct 16, 2026
Common StockF388$27.02$2.38K6,768,605IndirectSee footnote
SaleOct 16, 2026
Common StockF421$27.02$567.421,579,324IndirectSee footnote
SaleOct 16, 2026
Common StockF525$27.02$675.501,890,817IndirectSee footnote
SaleOct 15, 2026
Common StockF1F23,024$27.73$83.86K182,139IndirectSee footnote
SaleOct 15, 2026
Common StockF29$28.26$254.34182,130IndirectSee footnote
SaleOct 15, 2026
Common StockF1F3112,392$27.73$3.12M6,769,018IndirectSee footnote
SaleOct 15, 2026
Common StockF3325$28.26$9.18K6,768,693IndirectSee footnote
SaleOct 15, 2026
Common StockF1F426,224$27.73$727.19K1,579,421IndirectSee footnote
SaleOct 15, 2026
Common StockF476$28.26$2.15K1,579,345IndirectSee footnote
SaleOct 15, 2026
Common StockF1F531,397$27.73$870.64K1,890,932IndirectSee footnote
SaleOct 15, 2026
Common StockF590$28.26$2.54K1,890,842IndirectSee footnote
Filing footnotes · 5
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $28.23, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  2. F2These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  3. F3These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  4. F4These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  5. F5These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
Open on SEC EDGAR
Nicholas NaclerioDirector
4
Filed Apr 20, 2026Period of report Apr 16, 20260001534166-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseApr 20, 2026
Common StockF6235,294$17.00$4.00M507,076IndirectSee footnote
Filing footnotes · 8
  1. F1The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1:2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the "IPO").
  2. F2The securities are held by Illumina Innovation Fund II, L.P. ("IIF II"). Illumina Innovation Fund II GP, L.L.C. ("IIF II GP") is the general partner of IIF II. The reporting person, a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and the reporting person disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any.
  3. F3The Series B Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.271 basis and has no expiration date. The Series B Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the IPO.
  4. F4Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO.
  5. F5Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85.
  6. F6The securities are held by Illumina Innovation Fund III, L.P. ("IIF III"). Illumina Innovation Fund III GP, L.L.C. ("IIF II GP") is the general partner of IIF III. The reporting person, a member of the Issuer's board of directors, is the sole managing member of IIF III GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF III. Each of IIF III GP and the reporting person disclaim beneficial ownership over the securities held by IIF III, except to the extent of their respective pecuniary interests therein, if any.
  7. F7Represents the grant of restricted stock units ("RSUs"). The RSUs vest 1/3rd on each of April 20, 2027, April 20, 2028 and April 20, 2029, subject to the reporting person's continuous service as of each such vesting date.
  8. F8One-third of the shares subject to the grant will vest on April 16, 2027 and the remainder of the shares subject to the grant will vest in equal monthly installments thereafter through April 16, 2029, subject to the reporting person's continuous service through each such vesting date.
Open on SEC EDGAR
Illumina Innovation Fund II GP, L.L.C.10% owner
Illumina Innovation Fund III GP, L.L.C.10% owner
Illumina Innovation Fund III, L.P.10% owner
Illumina Innovation Fund II, L.P.10% owner
Naclerio Nicholas10% owner
4
Filed Apr 20, 2026Period of report Apr 16, 20260001193125-26-164634
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseApr 20, 2026
Common StockF6235,294$17.00$4.00M507,076IndirectSee footnote
Filing footnotes · 6
  1. F1The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the "IPO").
  2. F2The securities are held by Illumina Innovation Fund II, L.P. ("IIF II"). Illumina Innovation Fund II GP, L.L.C. ("IIF II GP") is the general partner of IIF II. Nicholas Naclerio ("Mr. Naclerio"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any.
  3. F3The Series B Preferred Stock is convertible into shares of Class B Common Stock on a 1-for-2.271 basis and has no expiration date. The Series B Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the IPO.
  4. F4Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO.
  5. F5Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85.
  6. F6The securities are held by Illumina Innovation Fund III, L.P. ("IIF III"). Illumina Innovation Fund III GP, L.L.C. ("IIF III GP") is the general partner of IIF III. Mr. Naclerio, a member of the Issuer's board of directors, is the sole managing member of IIF III GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF III. Each of IIF III GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF III, except to the extent of their respective pecuniary interests therein, if any.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.